Independent Solutions Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-4,920
Closed -$252K 172
2023
Q4
$252K Sell
4,920
-9,490
-66% -$498K 0.06% 149
2023
Q3
$836K Buy
+14,410
New +$883K 0.22% 102
2023
Q2
Sell
-4,945
Closed -$343K 221
2023
Q1
$343K Buy
4,945
+927
+23% +$65.4K 0.1% 147
2022
Q4
$289K Buy
4,018
+46
+1% +$3.47K 0.09% 167
2022
Q3
$282K Buy
3,972
+113
+3% +$8.2K 0.09% 164
2022
Q2
$297K Buy
+3,859
New +$294K 0.09% 164
2021
Q4
Sell
-5,929
Closed -$351K 231
2021
Q3
$351K Buy
5,929
+1,000
+20% +$65.9K 0.09% 166
2021
Q2
$329K Buy
+4,929
New +$321K 0.08% 166

Other funds holding BMY

Independent Solutions Wealth Management's BMY Position: Q1 2024 in Review

Independent Solutions Wealth Management sold out of Bristol-Myers Squibb (BMY) in Q1 2024, closing a stake of 4,920 shares — an estimated $252K sold.

Independent Solutions Wealth Management first reported a position in BMY in Q2 2021 and held it in 8 quarters. The position peaked at $836K in Q3 2023. 2,339 funds tracked by Wall St. Rank hold BMY as of Q1 2024.

  • Independent Solutions Wealth Management reported no remaining Bristol-Myers Squibb position as of Q1 2024 after selling out during the quarter.
  • Independent Solutions Wealth Management sold 4,920 Bristol-Myers Squibb shares in Q1 2024, an estimated $252K.
  • Independent Solutions Wealth Management first reported a position in Bristol-Myers Squibb in Q2 2021 and held it in 8 quarters.
  • Independent Solutions Wealth Management's Bristol-Myers Squibb position peaked at $836K in Q3 2023.
  • 2,339 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2024.

Based on Independent Solutions Wealth Management's 13F filing for Q1 2024, filed 19 Dec 2024.